EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utility of Fine Needle Aspiration Supernatant for Real‐Time PCR –Based Mutation Analysis in Non–Small Cell Lung Cancer

Adeyinka Akinsanya iD, Riley Gorden iD, Madison Rector, Hamna Muhammad iD, Melissa Randolph iD, Matt Sperling, Kemin Xu iD, Sheila Segura iD, Omer Saeed iD, Tieying Hou iD

Diagnostic Cytopathology · 2026

DOI: 10.1002/dc.70184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostic Cytopathology, 2026. Verfasst von Adeyinka Akinsanya und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Indiana University, School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Real-Time Polymerase Chain Reaction. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Pathology and Laboratory Medicine, Indiana U.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The emergence of personalized therapy and molecular sequencing has significantly transformed the management of advanced non–small cell lung carcinoma (NSCLC). Supernatants obtained from fine needle aspiration (FNA) have been shown to be a reliable source of high‐quality nucleic acid for molecular testing. One pre‐analytic factor that may influence the success of molecular analysis is the collection medium used for the FNA rinse.

Methods

This prospective study evaluated 31 FNA specimens collected in three different media—CytoRich Red, 10% neutral buffered formalin, or 10% bovine serum albumin (BSA)—to assess their impact on DNA yield and real‐time polymerase chain reaction (RT‐PCR) outcomes for KRAS ( Kirsten rat sarcoma viral oncogene homolog) and/or EGFR (epidermal growth factor receptor) mutations. DNA extraction was performed using the QIAamp DNA FFPE (formalin‐fixed paraffin‐embedded) Tissue Kit (Qiagen), and RT‐PCR was conducted using the QIAGEN therascreen EGFR or KRAS RGQ PCR kits. Concurrent direct smears or formalin‐fixed, paraffin‐embedded tissue from a cell block or core biopsy served as standard controls.

Results

In the CytoRich Red group, 11 specimens (9 adenocarcinomas and 2 NSCLC) were analyzed. All 11 specimens generated results concordant with standard controls. One specimen required repeat DNA extraction due to initial pre‐test quality control failure. The formalin group included 12 specimens (7 squamous cell carcinomas [SCC], 3 adenocarcinomas, 1 NSCLC, and 1 large cell neuroendocrine carcinoma). Nine specimens produced concordant results with controls. Two specimens were negative for EGFR mutations, although the corresponding control tissues were not tested. Six required repeat DNA extraction because of initial pre‐test failure, and one specimen remained invalid after re‐extraction. Eight specimens were collected in BSA (5 adenocarcinomas, 2 NSCLC, and 1 SCC). Five produced concordant results with standard controls, while three specimens failed PCR pre‐tests despite repeat DNA extraction.

Conclusion

In this small cohort, CytoRich Red demonstrated reliable performance for RT‐PCR‐based mutation testing. FNA supernatant represents a practical alternative specimen for lung cancer molecular analysis and may optimize specimen utilization while preserving cell block material.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsReal-Time Polymerase Chain ReactionHumansBiopsy, Fine-NeedleDNA Mutational AnalysisMutationErbB ReceptorsMaleProto-Oncogene Proteins p21(ras)FemaleProspective Studies

Stichwörter der Autor:innen

collecting mediumfine needle aspirationnon‐small carcinoma lung cancerreal‐time PCRsupernatant

Substanzen

ErbB ReceptorsProto-Oncogene Proteins p21(ras)KRAS protein, human

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Indiana University, School of Medicine, Indianapolis, Indiana, USA.

ORCID-Profile: Adeyinka Akinsanya, Riley Gorden, Hamna Muhammad, Melissa Randolph, Kemin Xu, Sheila Segura, Omer Saeed, Tieying Hou

Förderung

  • Department of Pathology and Laboratory Medicine, Indiana U

Zitieren

APA

Akinsanya, A., Gorden, R., Rector, M., Muhammad, H., Randolph, M., Sperling, M., Xu, K., Segura, S., Saeed, O., & Hou, T. (2026). Utility of Fine Needle Aspiration Supernatant for Real‐Time PCR –Based Mutation Analysis in Non–Small Cell Lung Cancer. Diagnostic Cytopathology. https://doi.org/10.1002/dc.70184

Vancouver

Akinsanya A, Gorden R, Rector M, Muhammad H, Randolph M, Sperling M, et al. Utility of Fine Needle Aspiration Supernatant for Real‐Time PCR –Based Mutation Analysis in Non–Small Cell Lung Cancer. Diagnostic Cytopathology. 2026. doi:10.1002/dc.70184

BibTeX
@article{Akinsanya2026,
  author = {Akinsanya, Adeyinka and Gorden, Riley and Rector, Madison and Muhammad, Hamna and Randolph, Melissa and Sperling, Matt and Xu, Kemin and Segura, Sheila and Saeed, Omer and Hou, Tieying},
  title = {Utility of Fine Needle Aspiration Supernatant for Real‐Time PCR –Based Mutation Analysis in Non–Small Cell Lung Cancer},
  journal = {Diagnostic Cytopathology},
  year = {2026},
  doi = {10.1002/dc.70184}
}
Kostenlos starten →